Global Parkinson Disease Drug Market Insights And Forecast To 2028

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Market by Application
1.3.1 Global Parkinson Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Parkinson Disease Drug Market Perspective (2017-2028)
2.2 Parkinson Disease Drug Growth Trends by Region
2.2.1 Parkinson Disease Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Parkinson Disease Drug Historic Market Size by Region (2017-2022)
2.2.3 Parkinson Disease Drug Forecasted Market Size by Region (2023-2028)
2.3 Parkinson Disease Drug Market Dynamics
2.3.1 Parkinson Disease Drug Industry Trends
2.3.2 Parkinson Disease Drug Market Drivers
2.3.3 Parkinson Disease Drug Market Challenges
2.3.4 Parkinson Disease Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson Disease Drug Players by Revenue
3.1.1 Global Top Parkinson Disease Drug Players by Revenue (2017-2022)
3.1.2 Global Parkinson Disease Drug Revenue Market Share by Players (2017-2022)
3.2 Global Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Parkinson Disease Drug Revenue
3.4 Global Parkinson Disease Drug Market Concentration Ratio
3.4.1 Global Parkinson Disease Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson Disease Drug Revenue in 2021
3.5 Parkinson Disease Drug Key Players Head office and Area Served
3.6 Key Players Parkinson Disease Drug Product Solution and Service
3.7 Date of Enter into Parkinson Disease Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson Disease Drug Breakdown Data by Type
4.1 Global Parkinson Disease Drug Historic Market Size by Type (2017-2022)
4.2 Global Parkinson Disease Drug Forecasted Market Size by Type (2023-2028)
5 Parkinson Disease Drug Breakdown Data by Application
5.1 Global Parkinson Disease Drug Historic Market Size by Application (2017-2022)
5.2 Global Parkinson Disease Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Parkinson Disease Drug Market Size (2017-2028)
6.2 North America Parkinson Disease Drug Market Size by Type
6.2.1 North America Parkinson Disease Drug Market Size by Type (2017-2022)
6.2.2 North America Parkinson Disease Drug Market Size by Type (2023-2028)
6.2.3 North America Parkinson Disease Drug Market Share by Type (2017-2028)
6.3 North America Parkinson Disease Drug Market Size by Application
6.3.1 North America Parkinson Disease Drug Market Size by Application (2017-2022)
6.3.2 North America Parkinson Disease Drug Market Size by Application (2023-2028)
6.3.3 North America Parkinson Disease Drug Market Share by Application (2017-2028)
6.4 North America Parkinson Disease Drug Market Size by Country
6.4.1 North America Parkinson Disease Drug Market Size by Country (2017-2022)
6.4.2 North America Parkinson Disease Drug Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Parkinson Disease Drug Market Size (2017-2028)
7.2 Europe Parkinson Disease Drug Market Size by Type
7.2.1 Europe Parkinson Disease Drug Market Size by Type (2017-2022)
7.2.2 Europe Parkinson Disease Drug Market Size by Type (2023-2028)
7.2.3 Europe Parkinson Disease Drug Market Share by Type (2017-2028)
7.3 Europe Parkinson Disease Drug Market Size by Application
7.3.1 Europe Parkinson Disease Drug Market Size by Application (2017-2022)
7.3.2 Europe Parkinson Disease Drug Market Size by Application (2023-2028)
7.3.3 Europe Parkinson Disease Drug Market Share by Application (2017-2028)
7.4 Europe Parkinson Disease Drug Market Size by Country
7.4.1 Europe Parkinson Disease Drug Market Size by Country (2017-2022)
7.4.2 Europe Parkinson Disease Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Parkinson Disease Drug Market Size (2017-2028)
8.2 Asia-Pacific Parkinson Disease Drug Market Size by Type
8.2.1 Asia-Pacific Parkinson Disease Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Parkinson Disease Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Parkinson Disease Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Parkinson Disease Drug Market Size by Application
8.3.1 Asia-Pacific Parkinson Disease Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Parkinson Disease Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Parkinson Disease Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Parkinson Disease Drug Market Size by Region
8.4.1 Asia-Pacific Parkinson Disease Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Parkinson Disease Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Parkinson Disease Drug Market Size (2017-2028)
9.2 Latin America Parkinson Disease Drug Market Size by Type
9.2.1 Latin America Parkinson Disease Drug Market Size by Type (2017-2022)
9.2.2 Latin America Parkinson Disease Drug Market Size by Type (2023-2028)
9.2.3 Latin America Parkinson Disease Drug Market Share by Type (2017-2028)
9.3 Latin America Parkinson Disease Drug Market Size by Application
9.3.1 Latin America Parkinson Disease Drug Market Size by Application (2017-2022)
9.3.2 Latin America Parkinson Disease Drug Market Size by Application (2023-2028)
9.3.3 Latin America Parkinson Disease Drug Market Share by Application (2017-2028)
9.4 Latin America Parkinson Disease Drug Market Size by Country
9.4.1 Latin America Parkinson Disease Drug Market Size by Country (2017-2022)
9.4.2 Latin America Parkinson Disease Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson Disease Drug Market Size (2017-2028)
10.2 Middle East & Africa Parkinson Disease Drug Market Size by Type
10.2.1 Middle East & Africa Parkinson Disease Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Parkinson Disease Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Parkinson Disease Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Parkinson Disease Drug Market Size by Application
10.3.1 Middle East & Africa Parkinson Disease Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Parkinson Disease Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Parkinson Disease Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Parkinson Disease Drug Market Size by Country
10.4.1 Middle East & Africa Parkinson Disease Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Parkinson Disease Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Parkinson Disease Drug Introduction
11.1.4 Merck Revenue in Parkinson Disease Drug Business (2017-2022)
11.1.5 Merck Recent Developments
11.2 Akorn
11.2.1 Akorn Company Details
11.2.2 Akorn Business Overview
11.2.3 Akorn Parkinson Disease Drug Introduction
11.2.4 Akorn Revenue in Parkinson Disease Drug Business (2017-2022)
11.2.5 Akorn Recent Developments
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson Disease Drug Introduction
11.3.4 GSK Revenue in Parkinson Disease Drug Business (2017-2022)
11.3.5 GSK Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Parkinson Disease Drug Introduction
11.4.4 Novartis Revenue in Parkinson Disease Drug Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson Disease Drug Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2017-2022)
11.5.5 Boehringer Ingelheim Recent Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Details
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Parkinson Disease Drug Introduction
11.6.4 Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2017-2022)
11.6.5 Teva Pharmaceutical Recent Developments
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson Disease Drug Introduction
11.7.4 Abbvie Revenue in Parkinson Disease Drug Business (2017-2022)
11.7.5 Abbvie Recent Developments
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Details
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2017-2022)
11.8.5 Kyowa Hakko Kirin Pharma Recent Developments
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson Disease Drug Introduction
11.9.4 Astellas Pharma Revenue in Parkinson Disease Drug Business (2017-2022)
11.9.5 Astellas Pharma Recent Developments
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Company Details
11.10.2 Desitin Arzneimittel Business Overview
11.10.3 Desitin Arzneimittel Parkinson Disease Drug Introduction
11.10.4 Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2017-2022)
11.10.5 Desitin Arzneimittel Recent Developments
11.11 Endo Pharmaceuticals
11.11.1 Endo Pharmaceuticals Company Details
11.11.2 Endo Pharmaceuticals Business Overview
11.11.3 Endo Pharmaceuticals Parkinson Disease Drug Introduction
11.11.4 Endo Pharmaceuticals Revenue in Parkinson Disease Drug Business (2017-2022)
11.11.5 Endo Pharmaceuticals Recent Developments
11.12 F.Hoffmann-La Roche
11.12.1 F.Hoffmann-La Roche Company Details
11.12.2 F.Hoffmann-La Roche Business Overview
11.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Introduction
11.12.4 F.Hoffmann-La Roche Revenue in Parkinson Disease Drug Business (2017-2022)
11.12.5 F.Hoffmann-La Roche Recent Developments
11.13 H.Lundbeck
11.13.1 H.Lundbeck Company Details
11.13.2 H.Lundbeck Business Overview
11.13.3 H.Lundbeck Parkinson Disease Drug Introduction
11.13.4 H.Lundbeck Revenue in Parkinson Disease Drug Business (2017-2022)
11.13.5 H.Lundbeck Recent Developments
11.14 Valeant
11.14.1 Valeant Company Details
11.14.2 Valeant Business Overview
11.14.3 Valeant Parkinson Disease Drug Introduction
11.14.4 Valeant Revenue in Parkinson Disease Drug Business (2017-2022)
11.14.5 Valeant Recent Developments
11.15 Apokyn
11.15.1 Apokyn Company Details
11.15.2 Apokyn Business Overview
11.15.3 Apokyn Parkinson Disease Drug Introduction
11.15.4 Apokyn Revenue in Parkinson Disease Drug Business (2017-2022)
11.15.5 Apokyn Recent Developments
11.16 Orion
11.16.1 Orion Company Details
11.16.2 Orion Business Overview
11.16.3 Orion Parkinson Disease Drug Introduction
11.16.4 Orion Revenue in Parkinson Disease Drug Business (2017-2022)
11.16.5 Orion Recent Developments
11.17 Stada Arzneimittel
11.17.1 Stada Arzneimittel Company Details
11.17.2 Stada Arzneimittel Business Overview
11.17.3 Stada Arzneimittel Parkinson Disease Drug Introduction
11.17.4 Stada Arzneimittel Revenue in Parkinson Disease Drug Business (2017-2022)
11.17.5 Stada Arzneimittel Recent Developments
11.18 US WorldMeds
11.18.1 US WorldMeds Company Details
11.18.2 US WorldMeds Business Overview
11.18.3 US WorldMeds Parkinson Disease Drug Introduction
11.18.4 US WorldMeds Revenue in Parkinson Disease Drug Business (2017-2022)
11.18.5 US WorldMeds Recent Developments
11.19 Bausch Health
11.19.1 Bausch Health Company Details
11.19.2 Bausch Health Business Overview
11.19.3 Bausch Health Parkinson Disease Drug Introduction
11.19.4 Bausch Health Revenue in Parkinson Disease Drug Business (2017-2022)
11.19.5 Bausch Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Parkinson Disease Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Sinemet-CR
Table 3. Key Players of Trastal
Table 4. Key Players of Madopar
Table 5. Key Players of COMT Inhibitor
Table 6. Key Players of Other
Table 7. Global Parkinson Disease Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Parkinson Disease Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Parkinson Disease Drug Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Parkinson Disease Drug Market Share by Region (2017-2022)
Table 11. Global Parkinson Disease Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Parkinson Disease Drug Market Share by Region (2023-2028)
Table 13. Parkinson Disease Drug Market Trends
Table 14. Parkinson Disease Drug Market Drivers
Table 15. Parkinson Disease Drug Market Challenges
Table 16. Parkinson Disease Drug Market Restraints
Table 17. Global Parkinson Disease Drug Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Parkinson Disease Drug Revenue Share by Players (2017-2022)
Table 19. Global Top Parkinson Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Disease Drug as of 2021)
Table 20. Ranking of Global Top Parkinson Disease Drug Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Parkinson Disease Drug Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Parkinson Disease Drug Product Solution and Service
Table 24. Date of Enter into Parkinson Disease Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Parkinson Disease Drug Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Parkinson Disease Drug Revenue Market Share by Type (2017-2022)
Table 28. Global Parkinson Disease Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Parkinson Disease Drug Revenue Market Share by Type (2023-2028)
Table 30. Global Parkinson Disease Drug Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Parkinson Disease Drug Revenue Share by Application (2017-2022)
Table 32. Global Parkinson Disease Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Parkinson Disease Drug Revenue Share by Application (2023-2028)
Table 34. North America Parkinson Disease Drug Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Parkinson Disease Drug Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Parkinson Disease Drug Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Parkinson Disease Drug Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Parkinson Disease Drug Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Parkinson Disease Drug Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Parkinson Disease Drug Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Parkinson Disease Drug Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Parkinson Disease Drug Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Parkinson Disease Drug Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Parkinson Disease Drug Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Parkinson Disease Drug Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Parkinson Disease Drug Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Parkinson Disease Drug Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Parkinson Disease Drug Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Parkinson Disease Drug Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Parkinson Disease Drug Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Parkinson Disease Drug Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Parkinson Disease Drug Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Parkinson Disease Drug Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Parkinson Disease Drug Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Parkinson Disease Drug Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Parkinson Disease Drug Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Parkinson Disease Drug Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Parkinson Disease Drug Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Parkinson Disease Drug Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Parkinson Disease Drug Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Parkinson Disease Drug Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Parkinson Disease Drug Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Parkinson Disease Drug Market Size by Country (2023-2028) & (US$ Million)
Table 64. Merck Company Details
Table 65. Merck Business Overview
Table 66. Merck Parkinson Disease Drug Product
Table 67. Merck Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 68. Merck Recent Developments
Table 69. Akorn Company Details
Table 70. Akorn Business Overview
Table 71. Akorn Parkinson Disease Drug Product
Table 72. Akorn Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 73. Akorn Recent Developments
Table 74. GSK Company Details
Table 75. GSK Business Overview
Table 76. GSK Parkinson Disease Drug Product
Table 77. GSK Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 78. GSK Recent Developments
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Parkinson Disease Drug Product
Table 82. Novartis Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 83. Novartis Recent Developments
Table 84. Boehringer Ingelheim Company Details
Table 85. Boehringer Ingelheim Business Overview
Table 86. Boehringer Ingelheim Parkinson Disease Drug Product
Table 87. Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 88. Boehringer Ingelheim Recent Developments
Table 89. Teva Pharmaceutical Company Details
Table 90. Teva Pharmaceutical Business Overview
Table 91. Teva Pharmaceutical Parkinson Disease Drug Product
Table 92. Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 93. Teva Pharmaceutical Recent Developments
Table 94. Abbvie Company Details
Table 95. Abbvie Business Overview
Table 96. Abbvie Parkinson Disease Drug Product
Table 97. Abbvie Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 98. Abbvie Recent Developments
Table 99. Kyowa Hakko Kirin Pharma Company Details
Table 100. Kyowa Hakko Kirin Pharma Business Overview
Table 101. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product
Table 102. Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 103. Kyowa Hakko Kirin Pharma Recent Developments
Table 104. Astellas Pharma Company Details
Table 105. Astellas Pharma Business Overview
Table 106. Astellas Pharma Parkinson Disease Drug Product
Table 107. Astellas Pharma Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 108. Astellas Pharma Recent Developments
Table 109. Desitin Arzneimittel Company Details
Table 110. Desitin Arzneimittel Business Overview
Table 111. Desitin Arzneimittel Parkinson Disease Drug Product
Table 112. Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 113. Desitin Arzneimittel Recent Developments
Table 114. Endo Pharmaceuticals Company Details
Table 115. Endo Pharmaceuticals Business Overview
Table 116. Endo Pharmaceuticals Parkinson Disease Drug Product
Table 117. Endo Pharmaceuticals Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 118. Endo Pharmaceuticals Recent Developments
Table 119. F.Hoffmann-La Roche Company Details
Table 120. F.Hoffmann-La Roche Business Overview
Table 121. F.Hoffmann-La Roche Parkinson Disease Drug Product
Table 122. F.Hoffmann-La Roche Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 123. F.Hoffmann-La Roche Recent Developments
Table 124. H.Lundbeck Company Details
Table 125. H.Lundbeck Business Overview
Table 126. H.Lundbeck Parkinson Disease Drug Product
Table 127. H.Lundbeck Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 128. H.Lundbeck Recent Developments
Table 129. Valeant Company Details
Table 130. Valeant Business Overview
Table 131. Valeant Parkinson Disease Drug Product
Table 132. Valeant Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 133. Valeant Recent Developments
Table 134. Apokyn Company Details
Table 135. Apokyn Business Overview
Table 136. Apokyn Parkinson Disease Drug Product
Table 137. Apokyn Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 138. Apokyn Recent Developments
Table 139. Orion Company Details
Table 140. Orion Business Overview
Table 141. Orion Parkinson Disease Drug Product
Table 142. Orion Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 143. Orion Recent Developments
Table 144. Stada Arzneimittel Company Details
Table 145. Stada Arzneimittel Business Overview
Table 146. Stada Arzneimittel Parkinson Disease Drug Product
Table 147. Stada Arzneimittel Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 148. Stada Arzneimittel Recent Developments
Table 149. US WorldMeds Company Details
Table 150. US WorldMeds Business Overview
Table 151. US WorldMeds Parkinson Disease Drug Product
Table 152. US WorldMeds Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 153. US WorldMeds Recent Developments
Table 154. Bausch Health Company Details
Table 155. Bausch Health Business Overview
Table 156. Bausch Health Parkinson Disease Drug Product
Table 157. Bausch Health Revenue in Parkinson Disease Drug Business (2017-2022) & (US$ Million)
Table 158. Bausch Health Recent Developments
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson Disease Drug Market Share by Type: 2021 VS 2028
Figure 2. Sinemet-CR Features
Figure 3. Trastal Features
Figure 4. Madopar Features
Figure 5. COMT Inhibitor Features
Figure 6. Other Features
Figure 7. Global Parkinson Disease Drug Market Share by Application: 2021 VS 2028
Figure 8. Under 40 Years Old Case Studies
Figure 9. 40-65 Years Old Case Studies
Figure 10. Above 65 Years Old Case Studies
Figure 11. Parkinson Disease Drug Report Years Considered
Figure 12. Global Parkinson Disease Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Parkinson Disease Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Parkinson Disease Drug Market Share by Region: 2021 VS 2028
Figure 15. Global Parkinson Disease Drug Market Share by Players in 2021
Figure 16. Global Top Parkinson Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Disease Drug as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Parkinson Disease Drug Revenue in 2021
Figure 18. North America Parkinson Disease Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Parkinson Disease Drug Market Size Market Share by Type (2017-2028)
Figure 20. North America Parkinson Disease Drug Market Size Market Share by Application (2017-2028)
Figure 21. North America Parkinson Disease Drug Market Size Share by Country (2017-2028)
Figure 22. United States Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Parkinson Disease Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Parkinson Disease Drug Market Size Market Share by Type (2017-2028)
Figure 26. Europe Parkinson Disease Drug Market Size Market Share by Application (2017-2028)
Figure 27. Europe Parkinson Disease Drug Market Size Share by Country (2017-2028)
Figure 28. Germany Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Parkinson Disease Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Parkinson Disease Drug Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Parkinson Disease Drug Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Parkinson Disease Drug Market Size Share by Region (2017-2028)
Figure 38. China Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Latin America Parkinson Disease Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Parkinson Disease Drug Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Parkinson Disease Drug Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Parkinson Disease Drug Market Size Share by Country (2017-2028)
Figure 48. Mexico Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Parkinson Disease Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Parkinson Disease Drug Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Parkinson Disease Drug Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Parkinson Disease Drug Market Size Share by Country (2017-2028)
Figure 54. Turkey Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Parkinson Disease Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Merck Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 58. Akorn Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 59. GSK Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 60. Novartis Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 62. Teva Pharmaceutical Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 63. Abbvie Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 64. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 65. Astellas Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 66. Desitin Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 67. Endo Pharmaceuticals Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 68. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 69. H.Lundbeck Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 70. Valeant Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 71. Apokyn Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 72. Orion Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 73. Stada Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 74. US WorldMeds Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 75. Bausch Health Revenue Growth Rate in Parkinson Disease Drug Business (2017-2022)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.